Get startedLog in
    Picture of Entera Bio logo

    ENTX — Entera Bio News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Entera Bio Ltd reports results for the quarter ended December 31 - Earnings Summary

    Picture of Entera Bio logoEntera Bio
    02/04/2025 13:00
    Entera Bio Ltd ENTX.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -7 cents.  The lone analyst forecast for the quarter was for a loss of 8 cents per share.

Revenue was $82.00 thousand​; analysts expected $40.00 thousand.

Entera Bio Ltd's reported EPS for the quarter was a loss of 22 cents​.

The company reported a quarterly loss of $8.4 million.

Entera Bio Ltd shares had fallen by 4.1% this quarter and lost 23.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Entera Bio Ltd is $10.00

This summary was machine generated from LSEG data April 2 at 11:59 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Dec. 31 2024-0.08-0.06Beat
    Sep. 30 2024-0.05-0.08Missed
    Jun. 30 2024-0.06-0.06Met
    Mar. 31 2024-0.06-0.05Beat

    Recent news on Entera Bio

    See all news